SCHEMBL24064296

SCHEMBL24064296

CCOC(C)Oc1ccc(O)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.41
ESR2 Q92731 7/20 0.41
AR P10275 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
TP53 P04637 1/20 0.38
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24064276 0.82 PCNA (0.44) ESR1ARSMN1; SMN2THRATHRB
SCHEMBL3720465 0.79 SMN1; SMN2 (0.46) ESR1ESR2ARSMN1; SMN2TDP1
SCHEMBL28550208 0.79 TDP1 (0.42) ESR1ESR2ARSMN1; SMN2TDP1
SCHEMBL4057110 0.78 LMNA (0.44) TDP1
SCHEMBL3720563 0.78 ALDH1A1 (0.48) ESR1ESR2TDP1TP53HPGD
SCHEMBL3852488 0.78 LMNA (0.52) TDP1THRBKMT2A
SCHEMBL19389539 0.77 LMNA (0.42) SMN1; SMN2TDP1CYP3A4HPGD
SCHEMBL5963165 0.77 LTA4H (0.47) ESR1ESR2ARTDP1CA12
SCHEMBL14813411 0.76 NPC1 (0.44) TDP1HPGDMEN1KMT2A
SCHEMBL23975529 0.75 CYP3A4 (0.47) ESR1ESR2CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210371376-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371376-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN H1-10, H1-0, OXSR1 ESR1 574/4885ESR2 2159/4885AR 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.